| AC5 | Adenylyl cyclase type 5 |
| Ankrd2 | ankyrin repeat domain 2 (stretch responsive muscle) |
| ATG5 | Autophagy related 5 |
| Avil | Advillin |
| Bcl2 | B cell leukemia/lymphoma 2 |
| Chst11 | Carbohydrate sulfotransferase 11 |
| Cisd1 | CDGSH iron sulfur domain 1 |
| Cisd2 | CDGSH iron sulfur domain 2 |
| Ctxn3 | Cortexin 3 |
| DE | Differentially expressed |
| DEXA | Dual energy X-ray absorptiometry |
| EE | Energy expenditure |
| ER | Endoplasmic reticulum |
| FFA | Free fatty acid |
| Fgf21 | Fibroblast growth factor 21 |
| FRD | False discovery rate |
| GH | Growth hormone |
| GHR/BP | Growth hormone receptor |
| Gdf15 | Growth differentiation factor 15 |
| HGPS | Hutchinson-Gilford progeria syndrome |
| IGF-1 | Insulin-like growth factor-1 |
| Irs1 | Insulin receptor substrate 1 |
| Irs2 | Insulin receptor substrate 2 |
| Islr2 | immunoglobulin superfamily containing leucine-rich repeat 2 |
| LFC | Log2 fold change |
| MAM | Mitochondria-associated membrane |
| MCAT | Mitochondrially-targeted catalase |
| MIF | Macrophage migration inhibitory factor |
| MRI | Magnetic resonance imaging |
| Mup10 | Major urinary protein 10 |
| Myh7 | Myosin, heavy polypeptide 7, cardiac muscle, beta |
| Myl2 | Myosin, light polypeptide 2, regulatory, cardiac, slow |
| Myl3 | Myosin, light polypeptide 3 |
| Myoz2 | Myozenin 2 |
| Ox2r | Orexin type 2 receptor |
| Pgc-1a | Peroxisome proliferator-activated receptor gamma coactivator-1 alpha |
| Pou1f1 | POU domain, class 1, transcription factor 1 |
| PKA | Protein kinase A |
| Prop1 | Paired like homeodomain factor 1 |
| Pten | Phosphatase and tensin homolog |
| REE | Resting energy expenditure |
| RER | Respiratory exchange ratio |
| ROS | Reactive oxygen species |
| Rpl34-ps1 | Ribosomal protein L34, pseudogene 1 |
| S6K1 | Ribosomal protein S6 kinase 1 |
| TEE | Total energy expenditure |
| Tmem40 | Transmembrane protein 40 |
| Ucp1 | Uncoupling protein 1 |